Proviral HIV-1 dynamics and evolution in patients receiving efficient long-term antiretroviral combination therapy

This publication has 20 references indexed in Scilit:

• Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
  Nature Medicine, 2002
• The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy
  Nature Medicine, 2000
• Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral Therapy
  JAMA, 1999
• Long-Term Effects of Antiretroviral Combination Therapy on HIV Type 1 DNA Levels
  AIDS Research and Human Retroviruses, 1999
• Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy
  New England Journal of Medicine, 1999
• Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy
  New England Journal of Medicine, 1999
• Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
  Nature Medicine, 1999
• Quantification of HIV-1 viral load in lymphoid and blood cells
  AIDS, 1997
• Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 Infection
  Science, 1997
• 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
  Proceedings of the National Academy of Sciences, 1985